Current status of cholesterol treatment in the community: The Minnesota Heart Survey

American Journal of Medicine

Volumn 102, Issue 2 A, 1997, Pages 37-42

  Luepker, Russell V ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

CORONARY RISK; DIET THERAPY; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK MANAGEMENT; UNITED STATES;

EID: 0030932434     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00466-X     Document Type: Article

References (23)

1. National Heart, Lung, and Blood Institute. Morbidity and Mortality. US Dept of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, 1994.
2. Kannel WB, Neaton JD, Wentworth D, et al, for the MRFIT Research Group. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Am Heart J. 1986;112:825-836.
3. Ross R, Harker L. Hyperlipidemia and atherosclerosis. Science. 1976;193:1094-1100.
4. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250.
5. Canner PL, Berge KG, Wenger NK, et al, for the Coronary Drug Project Research Group. Fifteen year mortality in coronary drug project patients: longterm benefit with niacin. J Am Coll Cardiol. 1986;8:1245-1255.
6. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984; 251:365-374.
7. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
8. Shepherd J, Cobbe SM, Ford I, et al, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.
9. The Multiple Risk Factor Intervention Trial Research Group. Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial. Circulation. 1996;94:946-951.
10. National Cholesterol Education Program. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med. 1988;148:36-69.
11. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. National Institutes of Health, National Heart, Lung, and Blood Institute; 1993. NIH publication 93-3095.
12. National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. US Department of Health and Human Services. Public Health Service, National Institutes of Health; 1990. NIH publication 90-3046.
13. National Cholesterol Education Program. Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. US Department of Health and Human Services. Public Health Service, National Institutes of Health; 1991. NIH publication 91-2732.
14. World Health Organization. Prevention of coronary heart disease: report of a WHO expert committee. World Health Organization, Geneva. World Health Organization Technical Report Series 678; 1982.
15. Luepker RV, Jacobs DR, Gillum RF, et al. Population risk of cardiovascular disease: the Minnesota Heart Survey. J Chron Dis. 1985;38:671-682.
16. Jacobs DR, Luepker RV, Mittelmark MB, et al. Community-wide prevention strategies: evaluation design of the Minnesota Heart Health Program. J Chron Dis. 1986;39:775-788.
17. Kofron PM, Råstam L, Pirie PL, et al. Physician practice for cardiovascular disease risk-factor reduction in six upper midwestern communities. J Fam Pract. 1991;32:49-55.
18. McGovern PG, Pankow JS, Shahar E, et al, for the Minnesota Heart Survey Investigators. Recent trends in acute coronary heart disease: mortality, morbidity, medical care, and risk factors. N Engl J Med. 1996;334:884-890.
19. Johnson CL, Rifkind BM, Sempos CT, et al. Declining serum total cholesterol levels among US adults: the National Health and Nutrition Examination Surveys. JAMA. 1993;269:3002-3008.
20. Popkin BM, Siega-Riz AM, Haines PS. A comparison of dietary trends among racial and socioeconomic groups in the United States. N Engl J Med. 1996;335:716-720.
21. Schucker B, Wittes JT, Cutler JA, et al. Change in physician perspective on cholesterol and heart disease: results from two national surveys. JAMA. 1987;258:3521-3526.
22. Manolio TA, Furberg CD, Wahl PW, et al. For the Cardiovascular Health Study Collaborative Research Group. Eligibility for cholesterol referral in community-dwelling older adults. Ann Intern Med. 1992;116:641-649.
23. Goldman L, Cook EF. The decline in ischemic heart disease mortality rates: an analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med. 1984;101:825-836.